Literature DB >> 19958600

Characterization of bacterial and fungal biofilms in chronic rhinosinusitis.

Andrew Foreman1, Alkis James Psaltis, Lor Wai Tan, Peter-John Wormald.   

Abstract

BACKGROUND: Conclusive evidence exists that biofilms are present on the mucosa of chronic rhinosinusitis (CRS) patients. Less is known about the species constituting these biofilms. This study developed a fluorescence in situ hybridization (FISH) protocol for characterization of bacterial and fungal biofilms in CRS.
METHODS: Fifty CRS patients and 10 controls were recruited. Bacteria FISH probes for Staphylococcus aureus, Haemophilus influenzae, and Pseudomonas aeruginosa and a universal probe for fungi were applied to sinus mucosal specimens and then analyzed using confocal scanning laser microscopy.
RESULTS: Thirty-six of 50 CRS patients had biofilms present in contrast to 0/10 controls, suggesting a role for biofilms in the pathogenesis of this disease. S. aureus was the most common biofilm-forming organism. Eleven of 50 CRS patients had characteristic fungal biofilms present.
CONCLUSION: This is the largest study of biofilms in CRS. It has validated mucosal tissue cryopreservation for delayed biofilm analysis. Fungal biofilms have been identified and the importance of S. aureus biofilms in the polymicrobial etiology of CRS is highlighted.

Entities:  

Mesh:

Year:  2009        PMID: 19958600     DOI: 10.2500/ajra.2009.23.3413

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  47 in total

1.  [Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; R Weber; K Hörmann
Journal:  HNO       Date:  2012-02       Impact factor: 1.284

2.  Antimicrobial photodynamic therapy treatment of chronic recurrent sinusitis biofilms.

Authors:  Merrill A Biel; Chet Sievert; Marina Usacheva; Matthew Teichert; Jim Balcom
Journal:  Int Forum Allergy Rhinol       Date:  2011-08-18       Impact factor: 3.858

3.  Relationship between bacterial biofilm and clinical features of patients with chronic rhinosinusitis.

Authors:  Han Li; Dehui Wang; Xicai Sun; Li Hu; Huapeng Yu; Jingjing Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-08       Impact factor: 2.503

4.  Evaluation of bacterial adherence and biofilm arrangements as new targets in treatment of chronic rhinosinusitis.

Authors:  Ahmed Ragab; Nira Essa; Nahed El-Raghy; Wafaa Zahran; A El Borolsy
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-04       Impact factor: 2.503

5.  Chronic rhinosinusitis as a multifactorial inflammatory disorder.

Authors:  Stella Lee; Andrew P Lane
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

6.  Relationship between biofilms and clinical features in patients with sinus fungal ball.

Authors:  Xiao Wang; Dong Dong; Jingliang Cheng; Xinjuan Fan; Yulin Zhao
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-31       Impact factor: 2.503

Review 7.  Therapy of Sinonasal Microbiome in CRS: A Critical Approach.

Authors:  Alkis J Psaltis; Peter-John Wormald
Journal:  Curr Allergy Asthma Rep       Date:  2017-09       Impact factor: 4.806

Review 8.  Understanding Biofilms in Chronic Sinusitis.

Authors:  Bobby A Tajudeen; Joseph S Schwartz; James N Palmer
Journal:  Curr Allergy Asthma Rep       Date:  2016-02       Impact factor: 4.806

Review 9.  A comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS).

Authors:  M Mahdavinia; A Keshavarzian; M C Tobin; A L Landay; R P Schleimer
Journal:  Clin Exp Allergy       Date:  2016-01       Impact factor: 5.018

10.  The effect of antimicrobial photodynamic therapy on human ciliated respiratory mucosa.

Authors:  Merrill A Biel; John W Jones; Lisa Pedigo; Aaron Gibbs; Nicolas Loebel
Journal:  Laryngoscope       Date:  2012-10-15       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.